Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Merck
Farmers Insurance
Accenture
Daiichi Sankyo
Citi
Harvard Business School
Healthtrust
Federal Trade Commission

Generated: May 21, 2018

DrugPatentWatch Database Preview

Par Form Company Profile

« Back to Dashboard

What is the competitive landscape for PAR FORM, and what generic and branded alternatives to PAR FORM drugs are available?

PAR FORM has five approved drugs.

There is one tentative approval on PAR FORM drugs.

Summary for Par Form
US Patents:0
Tradenames:5
Ingredients:5
NDAs:5
Patent Litigation for Par Form: See patent lawsuits for Par Form

Drugs and US Patents for Par Form

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Form FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride TABLET;ORAL 203836-001 Aug 19, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Par Form DICLOFENAC POTASSIUM diclofenac potassium FOR SOLUTION;ORAL 202964-001 May 2, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Par Form FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride TABLET;ORAL 203836-002 Aug 19, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Par Form LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 200908-003 Jul 10, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
AstraZeneca
Harvard Business School
Merck
Moodys
US Department of Justice
QuintilesIMS
Argus Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.